Could macrocytosis predict survival In advanced breast cancer patients that were treated with CDK 4-6 inhibitors?

Autor: Gültürk I; Istanbul Research and Training Hospital, Department of Medical Oncology, Istanbul, Turkey. Electronic address: gulturkilkay@gmail.com., Colak R; Bakirkoy Dr. Sadi Konuk Research and Training Hospital, Department of Medical Oncology, Istanbul, Turkey., Kapar C; Bakirkoy Dr. Sadi Konuk Research and Training Hospital, Department of Medical Oncology, Istanbul, Turkey., Guliyev M; Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of Medical Oncology, Istanbul, Turkey., Yıldırım C; Istanbul Research and Training Hospital, Department of Medical Oncology, Istanbul, Turkey., Yilmaz M; Bakirkoy Dr. Sadi Konuk Research and Training Hospital, Department of Medical Oncology, Istanbul, Turkey.

Publikováno v: Breast (Edinburgh, Scotland) [Breast] 2024 Dec; Vol. 78, pp. 103820. Date of Electronic Publication: 2024 Oct 10.

Sorafenib vs chemotherapy in the treatment of locally advanced or metastatic, radioactive iodine-refractory differentiated thyroid cancer: real-world data from Turkey.

Autor: Majidova N; Department of Internal Medicine, Division of Medical Oncology, Marmara University School of Medicine, Istanbul, Turkey., Aghamaliyeva S; Department of Internal Medicine, Division of Medical Oncology, Marmara University School of Medicine, Istanbul, Turkey., Guliyev M; Department of Internal Medicine, Division of Medical Oncology, Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa, Istanbul, Turkey., Dinc G; Department of Internal Medicine, Division of Medical Oncology, Professor Dr Cemil Tascioglu City Hospital, Istanbul, Turkiye., Akyıldız A; Department of Internal Medicine, Division of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey., Ozcan E; Department of Internal Medicine, Division of Medical Oncology, Trakya University School of Medicine, Edirne, Turkiye., Akdağ Kahvecıoglu F; Department of Internal Medicine, Division of Medical Oncology, Sakarya University School of Medicine, Sakarya, Turkiye., Çağrı Yıldırım H; Department of Internal Medicine, Division of Medical Oncology, Niğde Ömer Halisdemir University Training and Research Hospital, Nigde, Turkey., Sever N; Department of Internal Medicine, Division of Medical Oncology, Marmara University School of Medicine, Istanbul, Turkey., Guren AK; Department of Internal Medicine, Division of Medical Oncology, Marmara University School of Medicine, Istanbul, Turkey., Kocaaslan E; Department of Internal Medicine, Division of Medical Oncology, Marmara University School of Medicine, Istanbul, Turkey., Erel P; Department of Internal Medicine, Division of Medical Oncology, Marmara University School of Medicine, Istanbul, Turkey., Agyol Y; Department of Internal Medicine, Division of Medical Oncology, Marmara University School of Medicine, Istanbul, Turkey., Celebi A; Department of Internal Medicine, Division of Medical Oncology, Marmara University School of Medicine, Istanbul, Turkey., Arıkan R; Department of Internal Medicine, Division of Medical Oncology, Marmara University School of Medicine, Istanbul, Turkey., Isık S; Department of Internal Medicine, Division of Medical Oncology, Marmara University School of Medicine, Istanbul, Turkey., Bayoglu IV; Department of Internal Medicine, Division of Medical Oncology, Marmara University School of Medicine, Istanbul, Turkey., Demirci NS; Department of Internal Medicine, Division of Medical Oncology, Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa, Istanbul, Turkey., Dizdar Ö; Department of Internal Medicine, Division of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey., Hacıbekiroğlu I; Department of Internal Medicine, Division of Medical Oncology, Sakarya University School of Medicine, Sakarya, Turkiye., Kostek O; Department of Internal Medicine, Division of Medical Oncology, Marmara University School of Medicine, Istanbul, Turkey., Sarı M; Department of Internal Medicine, Division of Medical Oncology, Marmara University School of Medicine, Istanbul, Turkey.

Publikováno v: Journal of chemotherapy (Florence, Italy) [J Chemother] 2024 Nov 26, pp. 1-6. Date of Electronic Publication: 2024 Nov 26.

Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: a retrospective multi-center study by the Turkish Oncology Group (TOG).

Autor: Akyildiz A; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey. drakyildizarif@gmail.com., Guven DC; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey., Koksal B; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey., Karaoglan BB; Department of Medical Oncology, Ankara University Faculty of Medicine, Ankara, Turkey., Kivrak D; Department of Medical Oncology, University of Health Sciences, Antalya Training and Research Hospital, Antalya, Turkey., Ismayilov R; Department of Internal Medicine, Hacettepe University Medical School, Ankara, Turkey., Aslan F; Department of Medical Oncology, Ankara Medical Park Hospital, Ankara, Turkey., Sutcuoglu O; Department of Medical Oncology, Gazi University Faculty of Medicine, Ankara, Turkey., Yazici O; Department of Medical Oncology, Gazi University Faculty of Medicine, Ankara, Turkey., Kadioglu A; Department of Medical Oncology, Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey., Alan O; Department of Medical Oncology, Koç University, Istanbul, Turkey., Majidova N; Department of Medical Oncology, Marmara University, Pendik Training and Research Hospital, Istanbul, Turkey., Erciyestepe M; Department of Medical Oncology, Prof. Dr. Cemil Tascioglu City Hospital, Istanbul, Turkey., Ozcan E; Department of Medical Oncology, Trakya University Faculty of Medicine, Edirne, Turkey., Akdag G; Department of Medical Oncology, University of Health Science, Kartal Dr. Lutfi Kirdar City Hospital, Istanbul, Turkey., Taban H; Department of Medical Oncology, Samsun Training and Research Hospital, Samsun, Turkey., Kaya AO; Department of Medical Oncology, Biruni University Faculty of Medicine, Istanbul, Turkey., Guliyev M; Department of Medical Oncology, Istanbul University, Cerrahpasa School of Medicine, Istanbul, Turkey., Yildirim N; Department of Medical Oncology, Firat University Faculty of Medicine, Elazig, Turkey., Sakalar T; Department of Medical Oncology, Necip Fazil City Hospital, Kahramanmaras, Turkey., Yazilitas D; Department of Medical Oncology, Ankara Etlik City Hospital, Ankara, Turkey., Unal C; Department of Medical Oncology, Gayrettepe Florence Nightingale Hospital, Istanbul, Turkey., On S; Department of Oncology, Ege University Faculty of Medicine, Izmir, Turkey., Biter S; Department of Medical Oncology, Cukurova University Faculty of Medicine, Adana, Turkey., Demirci NS; Department of Medical Oncology, Istanbul University, Cerrahpasa School of Medicine, Istanbul, Turkey., Senler FC; Department of Medical Oncology, Ankara University Faculty of Medicine, Ankara, Turkey., Kemal Y; Department of Medical Oncology, Altinbas University Faculty of Medicine, Samsun, Turkey., Halil OD; Department of Medical Oncology, Near East University Hospital, Nicosia, Cyprus., Gullu I; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey., Aksoy S; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.

Publikováno v: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery [Eur Arch Otorhinolaryngol] 2024 Sep; Vol. 281 (9), pp. 4991-4999. Date of Electronic Publication: 2024 May 25.

The effects of low HER2 expression on survival in patients with metastatic breast cancer treated with CDK 4/6 inhibitors: a multicenter retrospective study.

Autor: Guliyev M; Division of Medical Oncology, Department of Internal Medicine, Cerrahpaşa Faculty of Medicine, İstanbul University-Cerrahpaşa, Istanbul, Turkey. drmuradguliyev@gmail.com., Şen GA; Division of Medical Oncology, Department of Internal Medicine, Cerrahpaşa Faculty of Medicine, İstanbul University-Cerrahpaşa, Istanbul, Turkey., Gültürk İ; Department of Medical Oncology, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey., Majidova N; Division of Medical Oncology, Department of Internal Medicine, Marmara University, Istanbul, Turkey., Akdağ G; Department of Medical Oncology, Kartal Dr. Lütf Kirdar City Hospital, Health Science University, Istanbul, Turkey., Ahadzade A; Department of Internal Medicine, Cerrahpaşa Faculty of Medicine, İstanbul University-Cerrahpaşa, Istanbul, Turkey., Turna H; Division of Medical Oncology, Department of Internal Medicine, Cerrahpaşa Faculty of Medicine, İstanbul University-Cerrahpaşa, Istanbul, Turkey., Demirci NS; Division of Medical Oncology, Department of Internal Medicine, Cerrahpaşa Faculty of Medicine, İstanbul University-Cerrahpaşa, Istanbul, Turkey.

Publikováno v: Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Jun; Vol. 205 (3), pp. 633-640. Date of Electronic Publication: 2024 Mar 25.

THE EFFECT OF COMPLETE REMOVABLE DENTURES ON BLOOD MICROCIRCULATION IN THE TISSUES OF THE PROSTHETIC BED

Autor: Aliyev M., Ismaylov D., Guliyev M.

A comparative study of the effect of hard and two-layer (with soft lining) bases of complete removable dentures on the tissues of the prosthetic bed was carried out using the method of laser Doppler flowmetry in 40 patients with complete secondary ad

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a8181bc52a1ced7398dbecf11162241